Loading, please wait...
Date: Jun 6, 2017 10:00 AM - 02:30 PM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Jun 06, 2017 10:00 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence. The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
|
||
|
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
|
|
Requirements for CE Credit
To receive CE credit, the participant must complete the entire course (be present for the entire live presentation, read the monograph in its entirety etc.), and complete the online pretest and post-test with a score greater than that specified for the course. The participant must also complete the online evaluation.
SIUE School of Pharmacy will transmit pharmacist activity completions to CPE Monitor. To view a list of all ACPE-accredited activities you have taken, log in to CPE Monitor at www.mycpemonitor. For information on the eligibility of this continuing education credit toward meeting your CME/CE requirements, please consult your professional association or state licensing board.
For questions regarding CME/CE activities, please email wsigang@siue.edu
It is the responsibility of the participant to ensure that all course credits earned are present in their cpe monitor profile within the timeframe specified by ACPE.
Registration closes on Jun 06, 2017
at 10:00 AM
Registration closes on Jun 06, 2017
at 10:00 AM
Registration Closed
Registration Closed
Healthcare providers in Southern Illinois continue to struggle with safe prescribing and monitoring of opioid analgesics. ILPMP data suggests that this trend is especially pronounced in the southern region of our State. The most recent CDC report from MMWR illustrates the continued rise of opioid related overdose deaths despite our best efforts.
Objectives
- Identify monitoring strategies and compliance to ensure appropriate use of opioid prescriptions
- Outline strategies to prevent opioid abuse by counseling patients on proper storage and disposal practice
- Describe validated risk screening tools for aberrant drug taking behaviors as well as their utility and limitations
- Select appropriate toxicology screening and interpret results to ensure safe use of opioids
Speaker(s)/Author(s)
|
Chris Herndon, Pharm.D., BCPS, CPE, FASHP
Brief Bio : Associate Professor, Department of Pharmacy Practice, SIUE and Clinical Assistant Professor, Department of Community and Family Medicine, St. Louis University School of Medicine. Clinical interest: Pain Management. Disclosure : Conflict of Interest Disclosures: The presenter has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported. |
Activity Number
0480-0000-17-009-L01-P
Date:
06/06/17
Time:
10:15 AM - 11:15 AM
CE Hours
1.00
Location
Mt. Vernon Hotel and Event Center
Registration Closed
Registration Closed
Registration Closed
Opioid prescribing for chronic pain can be excessive and unsafe, so pharmacists need to take additional steps to increase the safe use of pain medications.
Pharmacists will learn several ways in which they can easily collaborate with prescribers to alter their opioid prescribing and other aspects of pain treatment to decrease opioid exposure and increase safety of prescribing.
Objectives
- Explain the importance of maximizing the use of non-pharmacological interventions to treat chronic pain
- Describe the CDC Opioid Prescribing Guideline’s recommendation regarding dose limits
- Specify reasons why naloxone co-prescribing might be indicated
- List three other steps that can be taken to increase safety of opioid prescribing
Speaker(s)/Author(s)
|
Bob Twillman, Ph.D., FAPM
Brief Bio : Bob Twillman, Ph.D., is the Executive Director for the Academy of Integrative Pain Management. Dr. Twillman oversees federal and state pain policy developments and advocates for those supporting an integrative approach to managing pain. He also serves as Chair of the Prescription Monitoring Program Advisory Committee for the Kansas Board of Pharmacy. Dr. Twillman received his Ph.D. in Clinical Psychology at the University of California in Los Angeles, and maintains a volunteer faculty appointment as Clinical Associate Professor of Psychiatry and Behavioral Sciences at the University Of Kansas School Of Medicine in Kansas City, KS. Disclosure : The presenter has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported. |
Activity Number
0480-0000-17-008-L01-P
Date:
06/06/17
Time:
01:15 PM - 02:15 PM
CE Hours
1.00
Location
Mt. Vernon Hotel and Event Center
Registration Closed